Results 211 to 220 of about 214,982 (356)

Light‐Mediated Insulin and Amylin Secretion: Influence of Irradiation Parameters in Optogenetically Modified Mouse‐Pancreatic β Cells

Journal of Biophotonics, EarlyView.
This study demonstrates variation in photo‐induced secretion of insulin and amylin from Channelrhodopsin‐2 expressing MIN6 cells under different irradiation conditions. For the first time, an alteration in the relative ratio of amylin: insulin is observed with varying irradiation conditions.
Nidhi Maharwal, Rashmi Shrivastava, Khageswar Sahu, Shovan Kumar Majumder   +3 more
wiley   +1 more source

GLP-1 analog therapy and hemoglobin levels: Insights from a retrospective study. [PDF]

Saudi Med J
Almuammar SA, Alzahrani HK.
europepmc   +1 more source

Isolated hepatocytes as a model for the study of stable glucagon effects on mitochondrial respiratory functions [PDF]

, 1979
E.A. Siess, O. Wieland
openalex   +1 more source

Intranasal Naloxone During Recurrent Exercise in Individuals with Type‐1 Diabetes Mellitus: Evaluation of the Clinical Predictors of Pharmacokinetics and Exposure–Response

The Journal of Clinical Pharmacology, EarlyView.
Abstract Impaired awareness of hypoglycemia (IAH) impacts 25%–30% of individuals with type 1 diabetes mellitus (T1D), potentially leading to severe outcomes due to reduced symptom perception. Naloxone, a mu‐opioid receptor antagonist, shows promise as a preventive measure against IAH.
Omar N. Al Yacoub, Shen Cheng, Mohamed S. Fayed, James Fisher, Jillian Brooks, Elizabeth Seaquist, Anjali Kumar, Amir Moheet, Lynn Eberly, Lisa D. Coles   +9 more
wiley   +1 more source

GLP-1 and GIP may play a role in long-term weight trajectories after gastric bypass. [PDF]

Front Endocrinol (Lausanne)
Andrade S, Lobato CB, Machado M, Hartmann B, Holst JJ, Almeida RF, Nora M, Monteiro MP, Guimarães M, Pereira SS.   +9 more
europepmc   +1 more source

Glucose-Insulin-Potassium Therapy Guided by a Glucose-Controlled Insulin Infusion System in Acute Myocardinal Infarction [PDF]

, 1985
Ball, P., Bekemeyer, U., Djonlagic, H., Hauptmann, A., Heidbüchel, K., Müller-Esch, G., Osswald, P. M., Peters, A., Scriba, Peter Christian, Tybussek, R., Wood, W. G.   +10 more
core   +1 more source

Glucagon‐releasing activity of guanidine compounds in mouse pancreatic islets [PDF]

, 1976
José Marco, Consuelo Calle, J A Hedo, María Luisa Villanueva   +3 more
openalex   +1 more source

Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects

The Journal of Clinical Pharmacology, EarlyView.
Abstract Recognition of benefits and adverse effects of therapies in earlier clinical trial phases could improve the safety, efficiency, and cost of clinical trials. Using four clinical trials representing a diverse set of diseases and drug classes (EXSCEL: exenatide/GLP‐1 RA, SUGAR‐DM‐HF: empagliflozin/SGLT2i, PRADA: epirubicin/anthracycline, and ...
Jessica Chadwick, Colin Berry, Meredith A. Carpenter, Geeta Gulati, Siri Lagethon Heck, Michael A. Hinterberg, Rury R. Holman, Matthew M.Y. Lee, Torbjørn Omland, Clare Paterson, Mark C. Petrie, Naveed Sattar, Svati H. Shah, Sama Shrestha, Harald Sourij, Emma V Troth, Victoria Vinje, Stephen A. Williams   +17 more
wiley   +1 more source

Association between GLP-1 receptor agonists as a class and colorectal cancer risk: a meta-analysis of retrospective cohort studies. [PDF]

BMC Gastroenterol
Zhong Y, Wu T, Khan NU.
europepmc   +1 more source

Synthesis and isolation of a glucagon antagonist [PDF]

, 1979
Marvin D. Bregman, Victor J. Hruby
openalex   +1 more source